GLPHubglpresearchhub.com
Read-only archive. GLP Research Hub is a static community record — nothing here is for sale, no account is needed, and no vote you cast is counted. Why?
1.1k
c/glp1canada·posted 3 months ago by u/greta_perrin

[Results] 87 weeks, 25kg, and special authorization was the hard part

Private Plan Well Actually ×3 Slow Clap ×2

Something I noticed reading old threads that I have not seen said out loud.

The advice on province in this community changed substantially around the start of last year, and nobody went back and updated the older posts. So depending on which thread the search engine hands you, you get two contradictory answers with the same confidence.

I have listed what I think the current consensus is below. Correct me — that is the point of posting it.

1,788 up / 681 down72% upvoted38 commentsid 1h8pof18 Apr 2026

38 comments

20 in this archive, depth 5

best — the order this archive was captured in

u/formulary_fighterMOD165 points·3 months ago

Removed a chain here. The rule is one line long and it is not negotiable.

replysharereportpermalink
u/greta_perrinOP93 points·3 months ago

Disagree. What you are describing is consistent with special authorization, not with what you concluded.

replysharereportpermalink
u/hair_shed_hannah137 points·3 months ago

Strongly agree. Provincial variation is real.

replysharereportpermalink
u/aksel_palacios-9 points·3 months ago

the 13 province variation is real

replysharereportpermalink
u/the_poster_in_question_202665 points·3 months ago

the the Netherlands answer is not the the Netherlands answer

replysharereportpermalink
u/santiago_szabo77 points·3 months ago

This is the "correlation is mechanism" thing again. You changed three variables at once.

replysharereportpermalink
u/jarno_karlsen36 points·3 months ago

Respectfully this is a sample of one presented as a finding.

replysharereportpermalink
u/anders_karlsen10 points·3 months ago

special auth turnaround is province-specific

replysharereportpermalink
u/crosspost_bot_no8 points·3 months ago

Yeah, Poland coverage is not Poland coverage.

replysharereportpermalink
u/greta_perrinOP5 points·3 months ago

Stalled for 17 weeks, changed nothing, and it started moving again on week 45.

replysharereportpermalink
[removed]26 points·3 months ago

[removed by moderator]

replysharereportpermalink
u/careful_gradient3222 points·3 months ago·edited

Yeah, the Netherlands coverage is not the Netherlands coverage.

replysharereportpermalink
u/matias_salgado48 points·3 months ago

Yeah, the Netherlands coverage is not the Netherlands coverage.

replysharereportpermalink
u/cold_chromatogram36 points·3 months ago

Rodent data is rodent data. Dose scaling is not linear and the models tell you what to investigate, not what to expect.

replysharereportpermalink
u/greta_perrinOP15 points·3 months ago

The early fullness was genuinely awful for three weeks and then simply stopped. I know that is not useful information, but it is what happened.

replysharereportpermalink
u/solene_eriksen10 points·3 months ago

Australia here. Waited 17 months on a list, gave up, went private, and the total cost was roughly what I expected.

replysharereportpermalink
u/mariam_mensa27 points·3 months ago

Strongly agree. Provincial variation is real.

replysharereportpermalink
u/controversial_only13 points·3 months ago

provincial formularies differ sharply

replysharereportpermalink
u/hair_shed_hannah7 points·3 months ago

the 16 province variation is real

replysharereportpermalink
u/lina_almeida2 points·3 months ago

special auth turnaround is province-specific

replysharereportpermalink
Permalinked branches
Deep branches get their own page so a single reply chain can be linked and read on its own.
About c/glp1canada

Canadian access: provincial formulary differences, private plan coverage, the special-authorisation process, cross-border pricing arbitrage and why the Ontario answer is not the Alberta answer.

17kmembers
62submissions
Apr 2024created
submissions / month, last year
Sponsored

PeptideMeter Analytics

Independent testing plus vendor-level trend data. Community-funded, unaffiliated.

peptidemeter.com
More in c/glp1canada
c/glp1canada rules
  1. Name your province. Coverage is provincial.
  2. Private plan details: redact your group number.
  3. No cross-border purchasing instructions.
  4. Independent community. Nobody here sells anything, and anyone who tries is banned.
  5. Not medical advice. Describe what you did; never prescribe to a stranger.
  6. Claims need evidence. Batch numbers, dated screenshots, independent test reports, or a citation.
  7. No referral links, discount codes or affiliate URLs. Permanent ban, no appeal.
  8. No contact handles, wallet addresses or tracking numbers — they identify people.
  9. Be recognisably decent. Disagree hard, insult nobody.
Full rules and how they are enforced →
Moderators
u/canada_coverageu/formulary_fighteru/lane_watcher
Volunteers. Unpaid, unaffiliated, and reachable through modmail only.
Before you read on

Several compounds discussed on GLP Research Hub are sold for research use only and are not approved for human use anywhere. Nothing here is medical advice and none of it is written by your clinician. If a post reads like an instruction, treat it as a description of what one stranger did.

Full disclaimer →